Agree, only part of that equation I would question is, the revenue of a few hundred million that gets bandied around - it seems aspirational, but at the same time quite safe and conservative based on evidence of Japan sales etc. However, in that last video, Howie didn't give off a conservative vibe. I got the feeling they are going for clearly best in class, dominant treatment etc. It would be fascinating to know what their revenue target is and what they can convince BP is realistic. I assume the FDA decision on what claims they can make on the labelling/ packaging and consequently advertising will impact revenue expectations too. GLTAH.
Bot Chart, page-7663
-
- There are more pages in this discussion • 5,622 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 40.0¢ | 36.5¢ | $10.56M | 27.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 75348 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 514698 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |